The Lipitor war gets hotter for Watson Pharmaceuticals (WPI -4.3%) just hours after confirming...

|By:, SA News Editor

The Lipitor war gets hotter for Watson Pharmaceuticals (WPI -4.3%) just hours after confirming its generic launch, as reports surface that Indian drug maker Ranbaxy Laboratories is poised to receive its own approval from the FDA to launch its generic version of the drug.